Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 04 Feb 2025

Analysis of the prognostic value of thyroglobulin antibody change trends during follow-up after 131I treatment in patients with differentiated thyroid carcinoma

in Molecular and Cellular Oncology

Hua Ge
Wenxin Chen
Zhiyi Lin
Yuxuan Li
Shuting Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1496594

533 views

Original Research

Published on 31 Jan 2025

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer

in Molecular and Cellular Oncology

Chujin Ye
Zhiye Liu
Qifan Xie
Yanlin Tang
Jiayi Zeng
Ziwei Feng
Jiumin Liu
Haibiao Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1443571

733 views

Review

Published on 29 Jan 2025

CircRNAs in colorectal cancer: potential roles, clinical applications, and natural product-based regulation

in Molecular and Cellular Oncology

Jingjing Yang
Qiqi Fan
Yiyun Wang
Yuanyue Liu
Xiaoning Xu
Yeqi Liang
Jiakang Xie
Jiajie Li
Fengting Ai
Yong Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1525779

1,253 views

Review

Published on 27 Jan 2025

Research progress of circRNAs in bone-related diseases

in Molecular and Cellular Oncology

Xianming Hua
Lingfeng Yu
Hao Zhu
Yan Zhu
Gentao Fan
Guangxin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1481322

954 views

Systematic Review

Published on 24 Jan 2025

Research progress and perspectives on the application of tyramide signal amplification-based multiplex immunohistochemistry/immunofluorescence: a bibliometrics analysis

in Molecular and Cellular Oncology

Xiaotong Yu
Chen Huang
Yan Song
Chun Zhang
Debo You
XuRan Dong
DeFu Wu
Alan Keith Meeker
Hao Feng
Yuqing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1473414

963 views

Review

Published on 23 Jan 2025

Interactions between key genes and pathways in prostate cancer progression and therapy resistance

in Molecular and Cellular Oncology

Fan Wu
Hengsen Zhang
Miaomiao Hao

Frontiers in Oncology

doi 10.3389/fonc.2025.1467540

1,133 views

Original Research

Published on 21 Jan 2025

MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells

in Molecular and Cellular Oncology

Rowan Abdelbary
Manon Ragheb
Shereen A. El Sobky
Nagwa El-Badri
Nourhan Aboud
Ahmed Tawheed
Asmaa Gomaa
Mona Zidan
Ramy K. Aziz
Abd Elrahman Abouzid

Frontiers in Oncology

doi 10.3389/fonc.2024.1523068

1,674 views

Correction

Published on 17 Jan 2025

Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1

in Molecular and Cellular Oncology

Živa Frangež
Deborah Gérard
Zhaoyue He
Marios Gavriil
Yuniel Fernández-Marrero
S. Morteza Seyed Jafari
Robert E. Hunger
Philippe Lucarelli
Shida Yousefi
Thomas Sauter

Frontiers in Oncology

doi 10.3389/fonc.2025.1549776

428 views

Review

Published on 15 Jan 2025

Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics

in Molecular and Cellular Oncology

Zhirui Zhang
Wenhuan Song
Wenyu Chen
Wenze Cui
Wenyi Chen
Qinheng Zhang
Wenwen Ji
Yinglin Wang
Jiayi Wang
Wenhao Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1521251

1,221 views

Review

Published on 14 Jan 2025

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments

in Molecular and Cellular Oncology

Edgar Yebran Villegas-Vazquez
Francisco Pável Marín-Carrasco
Octavio Daniel Reyes-Hernández
Andrea S. Báez-González
Lilia Patricia Bustamante-Montes
Teresita Padilla-Benavides
Laura Itzel Quintas-Granados
Gabriela Figueroa-González

Frontiers in Oncology

doi 10.3389/fonc.2024.1514120

1,484 views

Original Research

Published on 13 Jan 2025

The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance

in Molecular and Cellular Oncology

Mingyu Zhao
Shanshuang Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1527226

756 views

Original Research

Published on 13 Jan 2025

Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy

in Molecular and Cellular Oncology

Zhenzhen Wang
Jing Yuan
Nan Zhou
Jianfeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1521179

589 views

Clinical Trial

Published on 09 Jan 2025

Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

in Molecular and Cellular Oncology

Tomasz Sirek
Katarzyna Król-Jatręga
Przemysław Borawski
Nikola Zmarzły
Dariusz Boroń
Piotr Ossowski
Olga Nowotny-Czupryna
Kacper Boroń
Dominika Janiszewska-Bil
Elżbieta Mitka-Krysiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1515387

957 views

Review

Published on 09 Jan 2025

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy

in Molecular and Cellular Oncology

Qixuan Feng
Yue Sun
Zhe Yang
Zhiyu Wang
Zhangyi Chen
Fang Liu
Lingxiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1522919

959 views

Review

Published on 07 Jan 2025

REV7: a small but mighty regulator of genome maintenance and cancer development

in Molecular and Cellular Oncology

Lara R. Maggs
Mitch McVey

Frontiers in Oncology

doi 10.3389/fonc.2024.1516165

1,115 views

Original Research

Published on 06 Jan 2025

Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9

in Molecular and Cellular Oncology

Qi Ouyang
Wenhui He
Yiping Guo
Lin Li
Ying Mao
Xiang Li
Shuanglin Xiang
Xiang Hu
Jun He

Frontiers in Oncology

doi 10.3389/fonc.2024.1517459

942 views